• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue4

RISK FACTOR RELATED TO BREAST CANCER

    Dr. Manoj Srivastava Dr. Nishee Srivastava

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 3436-3444

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Most breast enhancements are conflicting, meaning that they create a singular feature from evil that they are supposed to have happened by chance. There is no condition to attribute this to their youth, as the major legitimacy for conflicting breast disease is a mixture of internal, or hormonal, openings; lifestyle factors; standard parts; and the operation of mill physiology similar to that of DNA replication. The acquired breast compromising enhancement is truly amazing, making up 5% to 10% of the transitions. Disastrous improvement in the receiving breast occurs when a change in quality, called a change or change, is passed from parent to child within a family. Huge measures of those changes are in the harmful advancement silencer credits in the form of BRCA1, BRCA2, and PALB2. These characteristics usually go a long way from causing cells to grow out of control and turn into dangerous growths. Regardless, when a change occurs in these cells, it can cause them to grow out of control.
Keywords:
  • PDF (484 K)
  • XML
(2022). RISK FACTOR RELATED TO BREAST CANCER. European Journal of Molecular & Clinical Medicine, 8(4), 3436-3444.
Dr. Manoj Srivastava; Dr. Nishee Srivastava. "RISK FACTOR RELATED TO BREAST CANCER". European Journal of Molecular & Clinical Medicine, 8, 4, 2022, 3436-3444.
(2022). 'RISK FACTOR RELATED TO BREAST CANCER', European Journal of Molecular & Clinical Medicine, 8(4), pp. 3436-3444.
RISK FACTOR RELATED TO BREAST CANCER. European Journal of Molecular & Clinical Medicine, 2022; 8(4): 3436-3444.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 23
  • PDF Download: 36
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus